par Bunel, Valérian ;Antoine, Marie-Hélène ;Nortier, Joëlle ;Duez, Pierre ;Stévigny, Caroline
Référence Pharmaceutical biology, 53, 7, page (985-994)
Publication Publié, 2015
Référence Pharmaceutical biology, 53, 7, page (985-994)
Publication Publié, 2015
Article révisé par les pairs
Résumé : | Acute kidney injury (AKI) is often encountered in patients receiving cisplatin (CisPt), a chemotherapeutic drug that induces numerous toxic side effects. Techniques used to limit nephrotoxicity during CisPt treatment are not fully effective; about a third of patients experience AKI. New nephroprotective strategies, including pharmacological approaches, must be developed. |